Apoptosis is a mode of cell death that plays an important role in both pathological and physiological processes. Research during the last decade has delineated the entire machinery needed for cell death, and its constituents were found to pre-exist in cells. The apoptotic cascade is triggered when cells are exposed to an apoptotic stimulus. It has been known for several years that inhibitors of protein synthesis can potentiate apoptosis that is induced by cytokines and other inducers. Until 1996, it was not understood why protein synthesis inhibitors potentiate apoptosis. Then three reports appeared that suggested the role of the transcription factor NF-κB activation in protecting the cells from TNF-induced apoptosis. Since then several proteins have been identified that are regulated by NF-κB and are involved in cell survival, proliferation, and protection from apoptosis. It now seems that when a cell is attacked by an apoptotic stimulus, the cell responds first by activating anti-apoptotic mechanisms, which may or may not be followed by apoptosis. Whether or not a cell undergoes proliferation, the survival, or apoptosis, appears to involve a balance between the two mechanisms. Inhibitors of protein synthesis seem to suppress the appearance of protein that are involved in anti-apoptosis. The present review discusses how NF-κB controls apoptosis.
An intricate balance between cell growth and cell death drives the proper growth, development, and function of most tissues (Jacobson et al., 1997) . A vast amount of information has accumulated regarding the molecular mechanisms that govern cell growth, but the mechanisms by which cells regulate their own death still remains a matter of great intrigue, and have recently begun to acquire great importance.
One known mechanism, apoptosis, or programmed cell death, is a physiological process that is believed to be responsible for the deletion of unwanted cells during organ and tissue development, tissue homeostasis, and removal of self-reactive immune cells and pathologically induced tissue damage. Virus-infected cells are eliminated by the interaction with cytotoxic T-lymphocytes that kill the virus-infected cells by inducing apoptosis (Shibata et al., 1994; Darmon et al., 1995) . Cells that have DNA damage undergo apoptosis so as to eliminate cells that have accumulated genetic mutations and may become cancerous (Jaattela, 1999; Stambolic et al., 1999) . In addition to being activated during developmentrelated cell reduction, apoptosis can be triggered in many cell types by various stresses. These include chemotherapeutic agents, cytokines, ionizing radiation, osmotic stress, and expression of viral proteins such as E1A (Nagata, 1997) .
In the last few years, extensive research has revealed that cell death, whether at the single cell level, the tissue/organ level, or the organism level, is as important to life as cell survival. The critical role of apoptosis has been recognized in a wide variety of situations. These include immunomodulation, autoimmunity, sepsis, arthritis, inflammatory bowel disease, chronic heart failure, periodontal diseases, allograft rejection, neovascularization, obesity,
Mechanism of apoptosis
Besides dying by necrosis, multicellular organisms can initiate a series of events that activate intracellular proteases and ultimately result in the destruction of the cell. These are collectively known as apoptosis. Apoptotic cells undergo an orderly series of biochemical or morphological events including cell shrinkage, mitochondrial breakdown, and nuclear DNA fragmentation (Arends et al., 1991) . The dying cell degrades into subcellular membrane-bound vesicles called apoptotic bodies, which are ultimately removed by phagocytosis. Apoptosis is a molecular suicide program that is characterized by cytoplasmic shrinkage, nuclear condensation, and DNA fragmentation into 200-base pair fragments (Kerr et al., 1972; Cohen, 1993; Clarke and Clarke, 1995; Chinnaiyan and Dixit, 1996) . It is a genetically regulated mechanism and its deregulation can result in multistep carcinogenesis (McDonnell and Korsmeyer, 1991; Thompson, 1995; Gilmore et al., 1996) Apoptosis is brought about by activation of a family of proteins known as caspases (cysteinyl, aspartate-specific proteases) (Cohen, 1997; Green, 2000) . There are about 14 caspases that are involved in the process of apoptosis. Caspases are synthesized as proenzymes that are activated by proteolysis at two or three sites in order to remove the Nterminal peptide and divide the proenzyme into large and small subunits, which in some cases are joined by a linker domain. The mature caspase is a heterotetramer of two large and two small subunits (Ceretti et al., 1992; Thornberry et al., 1992) . All of the caspases are activated by cleavage at a specific aspartate residue and act in a cascade. They are ultimately responsible for the proteolysis of the cellular substrates that are responsible for apoptosis.
Poly (ADP-ribose) polymerase (PARP) is the most wellcharacterized substrate for several caspase in many cell systems. Intact PARP (116 kDa) is cleaved into two fragments (89 kDa and 24 kDa) during apoptosis (Kaufmann, 1989; Kaufmann, 1993) . Cleavage of PARP is a valuable indicator of apoptosis, but its biological relevance is unknown. Caspaseactivated deoxyribonuclease (CAD) is a cytoplasmic endonuclease whose activation is thought to be responsible for generating the oligonucleosomal DNA fragments that are the hallmark of apoptosis (Enari et al., 1998) .
DNA-dependent protein kinase (DNA-PK) is a DNA repair enzyme that is degraded during apoptosis by caspase 3 (Song et al., 1996) . Degradation of DNA-PK will result in a decrease in the capacity of the cell to repair damage of nuclear DNA, thus facilitating the breakdown of DNA that is associated with apoptosis. Caspase 6 is responsible for the degradation of lamin, which are the major structural components of the nuclear envelope (Takahashi et al., 1996) . Cleavage of the cytoskeletal proteins fodrin (Martin et al., 1995) , Gas 2 (Brancolini et al., 1995) , and actin (Mashima et al., 1995) during apoptosis may induce cell shrinkage and membrane blebbing, and alter cell signaling pathways. U1-70 kDa, a small ribonucleosomal particle that functions in the splicing of mRNA transcripts, is cleaved during apoptosis (CasciolaRosen et al., 1996) . Caspases also cleave initiation factors (Antoku et al., 1997) . This may inhibit translation during apoptosis. Caspases also cleave certain cell-signaling proteins, eg. PKC-δ and MEKK-1, which are rendered constitutively active and pro-apoptotic. In contrast, protein kinase B, which is involved in the anti-apoptotic pathway, is cleaved and inactivated by caspases (Widmann et al., 1998) A cell is induced to undergo apoptosis, either by internal signals arising within the cells, or by external signals triggered by death activators that bind to receptors located at the cell surface. Internal signals initiate apoptosis in the mitochondria with the release of cytochrome c (Green and Reed, 1998; Susin et al., 1998) . The mitochondrial pathway is controlled by the Bcl-2 family of proteins (Adams and Cory, 1998) . There are 15 members of the Bcl-2 protein family that share homology in at least one of three conserved domains (BH1BH4). These may either promote survival (e.g., Bcl-2, Bcl-xL), or promote apoptosis (e.g., Bax, or Bak) (Gross et al., 1999) . The Bcl-2 family of proteins register both positive and negative stimuli, and integrate them to determine whether the mitochondrial apoptotic pathway is turned on or off. Oncogenes encode mutated versions of the signaling proteins that control normal cell proliferation (e.g., Ras signaling). Another, the Raf oncoprotein, eventually initiates apoptosis when the cell receives an abnormal proliferative signal (Winston et al., 1996) .
The apoptotic program can also be initiated by the action of extracellular messengers, termed death ligands. These bind to the cell-surface receptors, termed death receptors, that activate intracellular signaling events that begin an apoptotic cascade (Ashkenazi and Dixit, 1998; Sheikh and Fornace, 2000) . Death receptors belong to the TNF receptor superfamily that is characterized by a cysteine-rich extracellular ligand-binding domain (Smith et al., 1994) . Death receptors contain a consensus module known as the death domain that is found in the intracellular portion of the molecule, and is involved in transducing the apoptotic signal (Nagata, 1997) . Fas and the TNF receptor are the two best-characterized death receptors, the cognate ligands for which are FasL and TNF, respectively.
Among all of the known physiological inducers of apoptosis in mammalian cells, the tumor necrosis factor (TNF) is perhaps the most potent and well studied. Many other members of the TNF superfamily also induce apoptosis. These include LT (lymphotoxin), FasL (fibroblast-associated ligand), TRAIL (TNF-related apoptosis-inducing ligand), DR3L (for death receptor 3 ligand or also known as TWEAK for a weak homologue of TNF), THANK (TNF homologue that activates apoptosis, NF-κB and JNK), and VEGI (vascular endothelial cell growth inhibitor) (Haridas et al., 1999; Mukhopadhyay et al., 1999) . Whether all these TNF family members induce apoptosis by the same mechanism as TNF is unknown. Besides killer cytokines, outlined previously, apoptosis is also induced by various chemotherapeutic agents.
Within the last few years, a series of biochemical steps have been identified in the apoptotic pathway that is induced by cytokines and chemotherapeutic agents. For instance in TNFinduced apoptosis, the TNF receptor is activated. Through its cytoplasmic death domain, it recruits a protein called the TNF receptor-associated death domain (TRADD). It then sequentially recruits the Fas-associated death domain (FADD) and FADD-like ICE (FLICE, also called caspase-8) (Rath and Aggarwal, 1999; Darnay and Aggarwal, 1999; Wallach et al., 1999) . The last activates caspase-9, which in turn activates caspase-3 (the executioner protease). This results in apoptosis.
In contrast to cytokines, chemotherapeutic agents induce cellular apoptosis by inducing the formation of mitochondrial transition pores, a rapid decrease in the mitochondrial transmembrane potential, and release of cytochrome C. The latter, in the presence of the protein Apaf-1, activates caspase-9, which then activates caspase-3. Recently, several studies have however suggested that these two receptor-mediated and non-receptor-mediated pathways that are initiated by cytokines and chemotherapeutic agents, respectively, are not exclusive of each other and share similar steps.
Most agents that induce apoptosis also activate NF-κB. Thus, it is not too surprising that almost all of the cytokines of the TNF superfamily and chemotherapeutic agents activate NF-κB. The TNF-induced activation of NF-κB (primarily consisting of p50 and p65 subunits) involves recruitment of the TNF receptor-associated factor (TRAF)-2 by TRADD, which then binds to NIK. TRADD also binds to the receptorinteracting protein (RIP). Either NIK or RIP then activate a kinase called the IκBα kinase (IKK), which in turn leads to the phosphorylation, ubiqutination, and degradation of IκBα (the inhibitory subunit of NF-κB), leading to NF-κB activation (Wallach et al., 1999) . Some recent studies exclude NIK from a role in the TNF-induced NF-κB activation. How chemotherapeutic agents activate NF-κB is not fully understood, but most likely it also involves the phosphorylation, ubiqitination, and degradation of IκBα. The subject of this review is how NF-κB activation is linked with the induction of apoptosis by TNF and chemotherapeutic agents.
Anti-apoptotic effects of NF-κB
Almost five years ago it was shown that TNF-induced apoptosis can be blocked by NF-κB activation (Liu et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996; Beg and Baltimore, 1996) . Rel/NF-κB transcription factors exercise their anti-apoptotic effects in a wide variety of cells to protect them from various apoptotic agents. They promote cell survival by inducing the transcription of anti-apoptotic genes ( Fig. 1) . Activation of NF-κB either up-regulates the activity of anti-apoptotic genes, or down-regulates the activity of apoptotic genes. The inhibition of NF-κB nuclear translocation enhances apoptotic killing by cytokines that belong to the TNF superfamily, ionizing radiation, overexpression of oncoproteins, chemotherapeutic agents, cytokines, phorbol esters, hyperoxia, hormones, and microorganisms (Table 1) .
Some earlier studies showed that the oncogene v-rel from the avian retrovirus reticuloendotheliosis virus strain can block apoptosis (for references see Gilmore, 1999) in chickens. Similarily, v-rel rendered chicken B cells resistant to MCF-7, human breast carcinoma; Panc TuI, human pancreatic adenocarcinoma; A549, nonsmall cell lung cancer; SKOV3ip1, human ovarian cancer cell line was generated from ascites developed in nu/nu mouse by administering an intraperitoneal injection of SK-OV-3, a human ovarian carcinoma cell line; MIAPaCa-2 and Capan-2, human pancreatic cancer cell lines; HT1080, fibrosarcoma; Mv1Lu and MDCK, epithelial cells; C4-1 and WEHI 231, B cells; PC12, rat adrenal pheochromocytoma; GSM 06, gastric mucosal cell line.
radiation-induced apoptosis (Neiman et al., 1991) . A large number of reports have demonstrated the anti-apoptotic effect of NF-κB in a wide variety of cell types. The protective role of NF-κB is shown in a large variety of cell types, including the human breast carcinoma (Liu et al., 1996) , T cells (Van Antwerp et al., 1996; Chu et al., 1997; Khoshnan et al., 2000) , fibroblasts and macrophages (Beg and Baltimore, 1996) , endothelial cells (Stehlik et al., 1998) , EBV-infected lymphoblastoid cells (Asso-bonnet et al., 1998) , non-small lung cancer cells , glomerular mesangial cells (Sugiyama et al., 1999) , human ovarian cancer cells (Shao et al., 1997) , human pancreatic cancer cell lines (Kajino et al., 2000) , Ewing sarcoma cells (Javelaud and Besancon, 2001) , cardiomyocytes (Bergmann et al., 2001) , mouse embryos , and HT1080 fibrosarcoma . Treatment of RelA-deficient (the transcriptionally active subunit of NF-κB) mouse fibroblasts and macrophages with TNF significantly reduced cell viability, whereas RelA +/+ cells were unaffected. In addition, reintroduction of RelA into RelA -/-fibroblasts enhanced survival, demonstrating that Rel A is required for protection from TNF (Beg and Baltimore, 1996) . Another report showed that activation of the NF-κB by TNF, ionizing radiation, or daunorubicin protects cells from apoptosis, whereas inhibition of NF-κB enhanced apoptotic killing by these reagents, but not by apoptotic stimuli that do not activate NF-κB . Van Antwerp et al. (1996) , however, showed that the sensitivity and kinetics of TNF-induced apoptosis are enhanced in a number of cell types that express a dominant-negative IκBα (an inhibitor of NF-κB). The continued expression of v-Rel is necessary to maintain the viability of transformed lymphoid cells, and enables primary spleen cells to escape apoptosis in culture (Zong et al., 1997) . Liu et al. (1996) used signaling proteins and showed the following: the recruitment of FADD to the TNFR1 complex mediates apoptosis; the recruitment of RIP and TRAF2 mediate NF-κB activation; and the activation of the latter protects cells against TNF-induced apoptosis. The substoichiometric TFIID subunit TAFII105 is essential for activation of anti-apoptotic genes in response to TNF-α, which serves as a transcriptional co-activator for NF-κB (Yamit-Hezi and Dikstein , 1998).
The adenovirus E1A protein inhibited the activation of NF-κB and rendered the cells more sensitive to TNF-induced apoptosis. This inhibition was brought about through the suppression of IκBα kinase (IKK) activity and IκB phosphorylation (Shao et al., 1999) . NF-κB can attenuate TNF-α-induced apoptosis without de novo protein synthesis in the human pancreatic cancer cell lines, MIA PaCa-2 and Capan-2. TNF-α-induced apoptosis was blocked by IL-1β, a potent inducer of NF-κB activation (Kajino et al., 2000) . These findings suggest that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-κB, and support the possibility that NF-κB exerts its anti-apoptotic action through protein-protein interaction.
The NF-κB cascade is important in the Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4 + lymphocytes (Khoshnan et al., 2000) . HuT-78, a lymphoblastoid T cell line with constitutive NF-κB activity, contains elevated levels of the Bcl-xL protein and, similar to the proliferating CD4 + T cells, is resistant to apoptotic stimuli such as anti-Fas and TNFα. In contrast, the same stimuli readily induced apoptosis in Jurkat cells without producing any detectable Bcl-xL expression.
The quinone reductase inhibitors dicoumarol and menadione block SAPK/JNK and NF-κB, and thereby potentiate apoptosis (Cross et al.,1999) . Javelaud and Besancon demonstrated that the repression of JNK activation by NF-κB is involved in the anti-apoptotic effect of this transcription factor in TNF α-treated Ewing sarcoma cells (Javelaud and Besancon, 2001 ). Also, NF-κB exercises its anti-apoptotic effects through NF-κB-inducing kinases (NIK). NIK induces PC12 cell differentiation and prevents apoptosis (Foehr et al., 2000) . Cardiomyocytes utilize the transcription factor NF-κB to activate survival factors in the context of TNF-α stimulation. As locally increased levels of TNFα have been detected in heart failure, NF-κB activity is essential for cellular homeostasis in the heart (Bergmann et al., 2001) .
NF-κB is required for TNF-mediated induction of the gene that encoded human c-IAP2. When overexpressed in mammalian cells, c-IAP2 activates NF-κB and suppresses TNF cytotoxicity. Both of these c-IAP2 activities are blocked in vivo by the co-expression of a dominant form of IκB that is resistant to TNF-induced degradation (Chu et al., 1997) . Functional coupling of NF-κB and c-IAP2 during the TNF response may provide a signal amplification loop that promotes cell survival rather than death. The iap genes function to protect the cell from undergoing apoptotic death in response to a variety of stimuli. The iap genes hiap1, hiap 2, and xiap are strongly up-regulated upon treatment of the endothelial cells with the inflammatory cytokines TNFα, IL-1β, and LPS, which in turn leads to the activation of NF-κB. This suggests that xiap represents one of the NF-κB-regulated genes that counteracts the apoptotic signals that are elicited by TNFα, thereby preventing endothelial cells from undergoing apoptosis during inflammation (Stehlik et al., 1998) .
Treatment of the WEH1 231 cells with N-tosyl-Lphenylalanine chloromethyl ketone, a protease inhibitor that prevents degradation of IκBα, or with low doses of pyrrolidine dithiocarbamate, selectively inhibited NF-κB activation and induced apoptosis (Wu et al., 1996) . Similarly, the microinjection of the WEHI 231 cells with either the IκBα-GST protein or a c-Rel affinity-purified antibody induced apoptosis (Wu et al., 1996) . Arlt et al. have shown that under certain conditions the resistance of pancreatic carcinoma cells to chemotherapy is due to their constitutive NF-κB rather than the transient induction of NF-κB by some anti-cancer drugs. . Exposure of normal keratinocytes to IFN-γ plus TPA produced a synergistic activation of NF-κB. They acquired a resistance to UV-light-induced apoptosis that was dependent on NF-κB, because the expression of a dominant negative form of IκBα overcame the resistance (Qin et al., 1999) . There is enough evidence to suggest that activation and proper regulation of NF-κB is essential for the acquisition of an apoptotic-resistant phenotype for epidermal-derived keratinocytes. Kolenko et al. (1999) demonstrated that the inhibition of NF-κB activity by cell permeable SN50 peptide in human T lymphocytes induces caspase-dependent apoptosis. Kawai et al. (1999) have shown that p53 is involved in NF-κB inactivation, and is required for X-ray-induced apoptosis in thymic lymphoma cells and normal thymocytes.
Oxidative stress induces apoptosis in human aortic endothelial cells through the down-regulation of bcl-2, translocation of bax, and up-regulation of p53, probably through NF-κB activation. Oxidative stress may play an important role in endothelial apoptosis that is mediated by hypoxia, through the activation of NF-κB (Aoki et al., 2001) . NF-κB is a redox-sensitive transcription factor that is activated by oxidative insult. Also, NF-κB activation can protect cells from apoptosis. When human alveolar epithelial (A549) cells were exposed to hyperoxia, NF-κB was activated and within minutes was translocated to the nucleus . Reactive oxygen species could act synergistically with TNFα, causing cytotoxicity via inhibition of a cytoprotective branch of TNFα signaling pathways that starts with NF-κB activation. Ginis et al. demonstrated that H 2 O 2 inhibited TNFα-induced accumulation of p65 in the nucleus, although it had no effect on the degradation of IκB in the cytoplasm (Ginis et al., 2000) .
Adenovirus protein E1B blocks TNF-induced apoptosis, whereas E1A enhances TNF-induced apoptosis through unknown mechanisms. Recent evidence indicates that the effect of these proteins is mediated through modulation of NF-κB activation (Shao et al., 1997) .
The growth arrest-specific 6 gene product (Gas6) is a growth and survival factor that is related to protein S. Gas6 induces a rapid and transient increase in nuclear NF-κB binding activity that is coupled to transcription activation. This plays a central role in promoting survival in NIH 3T3 cells (Demarchi et al., 2001) . MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase dependent manner (Zechner et al., 1998) . Limb girdle muscular dystrophy type 2A results in a decreased production of calpain 3. Calpain 3 is responsible for the IκBα turnover. Over expression of IκBα results in the sequestration of NF-κB outside the nucleus. Myonuclear apoptosis was caused by the down-regulation of NF-κB (Baghdiguian et al., 1999) . The stimulation of the CD95-and TRAIL-resistant human pancreatic adenocarcinoma cell line, Panc TuI, with an agonistic anti-CD95 antibody or TRAIL activates protein kinase C and NF-κB. The activation of PKC operates directly in a death receptor dependent manner in PancTuI cells and pancreatic tumor cells, protecting them from anti-CD95 and TRAIL-mediated apoptosis by preventing the loss of DeltaPsim and cytochrome c release, as well as by the induction of NF-κB (Trauzold et al., 2001) . Pharmacologic or molecular inhibition of the NF-κB pathway blocked cell survival in MCF-7 APO+ cells, while only molecular inhibition induced cytotoxicity in the APO-cells (Weldon et al., 2001) . TGF-α protected gastric mucosal cells against apoptosis that is induced by serum depletion or sodium butyrate in a dose-dependent manner. This anti-apoptotic effect of TGF-α was blocked by pre-treatment with reagents that can potentially inhibit NF-κB activation. This suggests that TGF-α plays an antiapoptotic role in gastric mucosal cells via the NF-κB-dependent pathway (Kanai et al., 2001) .
Mice deficient in the NF-κB 2 gene were challenged with the intracellular parasite Toxoplasma gondii. During the chronic phase of the infection, susceptibility of NF-κB knockout mice to toxoplasmic encephalitis was associated with a reduced capacity of their splenocytes to produce IFN-γ that is associated with a loss of CD4 + and CD8 + T cells. This loss of T cells correlated with the increased levels of apoptosis and with the elevated expression of the pro-apoptotic molecule Fas by T-cells from infected NF-κB knockout mice. This suggests a role of NF-κB in maintenance of T cell responses that are required for long-term resistance to Toxoplasma gondii (Caamano et al., 2000) .
How NF-κB suppresses apoptosis
Although it is clear that NF-κB activation plays a role in suppressing TNF-induced apoptosis, just how is only now beginning to emerge. Several genes that may play a role in blocking apoptosis, and whose expression is regulated by NF-κB, have been identified. These include cellular inhibitors of apoptosis (cIAP)-1 and cIAP-2, TRAF-1, and TRAF-2 (Chu et al., 1997; Stehlik et al., 1998; Wang et al., 1998) . cIAP-1, cIAP-2, and TRAF-1 are known to bind to TRAF-2, and TRAF-2 is required for NF-κB activation. Thus, how these proteins block apoptosis is unclear. Other reports show that TNF induces manganous superoxide dismutase (SOD), whose expression is also regulated by NF-κB. The overexpression of SOD induces resistance to TNF-induced apoptosis (Manna et al., 1998) . Also, the altered SOD expression in HeLa cells after low dose gamma-irradiation is responsible for NF-κB-mediated cisplatin resistance (Eichholtz-Wirth et al., 2000) . Insulin manifests its antiapoptotic signaling though the activation of NF-κB-dependent survival genes that encode TRAF-2 and SOD (Bertrand et al., 1999) . The TNF-inducible zinc finger protein A20 (Opipari et al., 1992 ) is regulated by NF-κB (Krikos et al., 1992) , and the role of this protein in the induction of resistance to TNF-induced apoptosis has been demonstrated (Opipari et al., 1992) . The expression of a protein that is critical in the regulation of the cell cycle, cyclin D1, is also regulated by NF-κB. This activity may contribute to the cell growth and differentiation function assigned to NF-κB (Guttridge et al., 1999; Hinz et al., 1999) .
The pro-survival Bcl-2 homolog Bfl-1/A1 is another gene whose transcription is regulated by NF-κB and blocks TNFinduced apoptosis (Wang, 1999; Zong et al., 1999) . There are other studies that show that Bcl-2 activates NF-κB through the degradation of the inhibitor IκBα (de Moissac et al., 1998) . Crawford et al. demonstrated that Bcl-2 over-expression protects photooxidative stress-induced apoptosis of photoreceptor cells through NF-κB preservation. The Ras/PI-3K/Akt pathway plays a critical role in cell survival. It now appears that this pathway is also linked to the activation of IKK, the kinase needed for IkBα phosphorylation and NF-κB activation. Akt may also play a cytoprotective role through activation of NF-κB (Romashkova and Makarov, 1999, Yang et al., 2001) . A NF-κB-independent cytoprotective pathway has also been described. The NF-κB activation that is induced by the over-expression of TRAF2 was found to be insufficient to protect cells from apoptosis that is induced by TNF and cycloheximide together. This indicates an essential role for additional components in the cytoprotective response (Natoli et al., 1998) .
While NF-κB activation blocks apoptosis, it seems that the activation of apoptosis also blocks NF-κB activation, suggesting a feedback loop. For instance, endothelial cells undergo apoptosis when deprived of growth factors. The surviving viable cells exhibit increased activity of NF-κB, whereas apoptotic cells show caspase-mediated cleavage of the NF-κB p65/RelA subunit. This results in the loss of carboxy-terminal transactivation domains and a transcriptionally inactive p65 molecule, which itself acts as a dominant-negative inhibitor of NF-κB, promoting apoptosis. In contrast, an uncleavable caspase-resistant p65 protects the cells from apoptosis. The generation of a dominant-negative fragment of p65 during apoptosis may be an efficient proapoptotic feedback mechanism between caspase activation and NF-κB inactivation (Levkau et al., 1999) . Similarly, apoptosis has been shown to promote a caspase-induced amino-terminal truncation of IκBα that functions as a stable inhibitor of NF-κB , thus further enhancing apoptosis. Fas (another member of the TNF receptor family) was also found to induce caspase 3-mediated proteolysis of both p50 and p65 subunits of NF-κB in T Jurkat cells, thus sensitizing the cells to apoptosis (Ravi et al., 1998) .
Pro-apoptotic activity of NF-κB
The decision of life or death in response to an inducing signal within a cell is dependent upon a delicate balance of positive and negative influences. While there are several reports that NF-κB activation protects cells from undergoing apoptosis that is induced by TNF or chemotherapeutic agents, there are also reports that suggest that NF-κB activation mediates apoptosis in response to a variety of inducers in a number of cell types. For instance, in murine clonal osteoblasts, the NF-κB activation mediated the TNF-induced apoptosis (Kitajima et al., 1996) . The suppression of the growth of CD34 + myeloid cells by TNF also correlated with the NF-κB activation . Apart from this, Fas activates NF-κB and induces apoptosis in T-cell lines by signaling pathways that are distinct from those induced by TNFα (Packham et al., 1997) . Human melanoma cells are protected against UV-induced apoptosis through the down-regulation of NF-κB activity and Fas expression (Ivanov and Ronai, 2000) . Oxidative stress induced apoptosis in human aortic endothelial cells through the downregulation of bcl-2, translocation of bax, and up-regulation of p53 that probably takes place through NF-κB activation. Oxidative stress may play an important role in endothelial apoptosis that is mediated by hypoxia through the activation of NF-κB (Aoki et al., 2001) . The activation of NF-κB is required for apoptosis, as has also been shown for other inducers such as H 2 O 2 (Dumont et al., 1999; Vollgraf et al., 1999) . Similarly, H 2 O 2 -induced apoptosis was not suppressed by hyperoxia-induced NF-κB activation . In pancreatic islets, A20 inhibited both apoptosis and NF-κB activation that is induced by cytokines. This suggests that NF-κB may actually mediate apoptosis (Grey et al., 1999) .
Apoptosis in HL-60 cells that is induced by chemotherapeutic agents, such as etoposide or 1-beta-Darabinofuranosylcytosine, was also found to require NF-κB activation since the suppression of NF-κB by PDTC also blocked apoptosis (Bessho et al., 1994) .
Recently, Stark et al. demonstrated that aspirin induces cell death by an active apoptotic process that involves nuclear translocation of NF-κB preceding cell death (Stark et al., 2001) . Helicobacter pylori induces NF-κB-mediated apoptosis in chronic gastritis (Gupta et al., 2001) . The apoptosis that is induced by alphavirus was also found to require the activation of NF-κB (Lin et al., 1995) , since thiol agents and Bcl-2 blocked both activities. During adenoviral infection, NF-κB mediates apoptosis through transcriptional activation of Fas (CD95) (Kuhnel et al., 2000) . Apoptosis in Ca ++ reperfusion injury of cultured astrocytes was also found to be mediated through NF-κB activation (Takuma et al., 1999) . The cell death-promoting role of NF-κB has also been demonstrated in focal cerebral malaria (Schneider et al., 1999) , as it has for the induction of apoptosis by doublestranded-RNA-dependent protein-kinase (PKR) (Gil et al., 1999) . Lin et al. (1998) showed that NF-κB can be proapoptotic or antiapoptotic, depending on the timing of the modulating NF-κB activity relative to the death stimulus. How NF-κB may mediate apoptosis is unclear, but the role of p53 and c-myc induction through NF-κB has been demonstrated (Nakai et al., 2000) . In addition, NF-κB is required for the anti-CD3-mediated apoptosis of double-positive thymocytes through a pathway that involves the regulation of the antiapoptotic gene bcl-XL ( Hettmann et al., 1999) . c-myc has also been implicated in the survival of certain cells such as hepatocytes (Bellas and Sonenshein, 1999) . These observations suggest that NF-κB activation not only negatively, but also positively regulates apoptosis. This idea has been further strengthened by studies on NMRI mice, Wistar rats, and WI-38 fibroblasts where aging induced a strong and consistent increase in the nuclear binding activity of NF-κB (Helenius et al., 1996) .
Evidence that apoptosis is unaffected by NF-kappaB
There are increasing reports that NF-κB activation plays little or no role in apoptosis. For instance, Cai et al. showed that the overexpression of IκBα, an inhibitor of NF-κB, in the human breast carcinoma MCF7 cells inhibits NF-κB activation, but not TNF-induced apoptosis. Similarly, in endothelial cells, A20 inhibited NF-κB activation without enhancing TNFinduced apoptosis (Ferran et al., 1998) . LPS-and IL-1-induced prolongation in the survival of endothelial cells did not require NF-κB activation (Zen et al., 1999) . The pro-and anti-apoptotic role of NF-κB appears to be determined more by the nature of the death stimulus than by the origin of the tissue (Kuhnel et al., 2000) . Bone morphogenetic protein (BMP)-2 and -4 inhibited the TNF-mediated apoptosis by inhibiting caspase-8 activation in C2C12 cells, a pluripotent mesenchymal cell line that has the potential to differentiate into osteoblasts, depending on BMP stimulation. The BMP/ Smad signaling pathway can inhibit TNF-mediated apoptosis independently of the pro-survival activity of NF-κB. This suggests that BMPs not only stimulate osteoblast differentiation, but also promote cell survival during the induction of bone formation. This offers new insights into the biological functions of BMPs (Chen et al., 2001) . There are proteins that associate with cytokine receptors, such as SODD (for silencer of death domain) (Jiang et al., 1999) , sentris (Okura et al., 1996) , and c-FLIP (Scaffidi et al., 1999) . These can also negatively regulate apoptosis, again independently of NF-κB.
The redox-sensitive transcription factor Ref-1 plays a critical role in the survival of endothelial cells in response to hypoxia and cytokines, including TNFα. The up-regulation of Ref-1 promotes endothelial cell survival in response to hypoxia and TNF through NF-κB independent and NF-κB-dependent signaling cascades (Hall et al., 2001) . The human non-small-cell lung carcinoma apoptosis induced by topoisomerase poisons, e.g. Etoposide, is not mediated by NF-κB, but can be manipulated by proteasome inhibitors (Tabata et al., 2001) . Why NF-κB plays a role in apoptosis that is induced by some agents and not others is unclear, but suggests that the apoptotic pathway varies from one inducer to another, and also perhaps from one cell type to another.
Conclusion
From this review, it is clear that apoptosis is regulated by mitochondria-dependent and -independent pathways that involve a series of proteins that pre-exist in the cells. Most of the agents that induce apoptosis also activate NF-κB, and the latter suppresses apoptosis in most cases. While it may appear paradoxical that the same agent could perform both functions, in reality it is not. The same stress that induces cells to die also provokes a self-defense response in the cell. How NF-κB plays an antiapoptitic role in some cells, pro-apoptotic in others, and no role in some, requires further understanding. It is possible that the activation of NF-κB alone is insufficient to regulate apoptosis, and that other transcription factors are involved. Most NF-κB-regulated genes (such as cyclooxygenase-2) play a critical role in inflammation, suggesting that inflammation can also negatively regulate apoptosis. Overall, this review describes our current understanding of the mechanism of the regulation of apoptosis, and the future direction of the research.
